Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scutellarin injection for acute cerebral infarction
ChiCTR2100048583Phase 4Not yet recruiting
- Sponsor
- The Third People's Hospital of Yunnan Province
- Start
- Jul 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of scutellarin in brain infarction and ischemic stroke (3 arms), sponsored by The Third People's Hospital of Yunnan Province. Primary endpoint: Homocysteine level. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
scutellarin
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR2100048583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048583.